Endogenous Psychedelics - The Hidden Chemistry of Autism

What if the same molecules that shape mystical experiences, DMT, bufotenin, serotonin, tryptamine, were also playing a role inside the autistic brain?
This presentation unpacks groundbreaking research:

• How endogenous psychedelics are produced in humans (by gut bacteria).
• Why altered serotonin and tryptamine metabolism may fuel core autism symptoms.
• The science of perception, what happens when the brain’s filters relax, allowing overwhelming sensory flow.
• New evidence that these compounds may act as biomarkers for extraordinary cognition and perception in autism.

The presentation asks a daring question: Could unlocking the mysteries of tryptamines open new frontiers in understanding, and helping, autism?
We are currenty designing a study in collaboration with Stanford and UC Davis to map the entire psychedelic metabolome in stool and plasma of 90 individuals affected with ASD compared to neurotypicals.